HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Targeted cardiac expression of soluble Fas prevents the development of heart failure in mice with cardiac-specific expression of MCP-1.

Abstract
Monocyte chemoattractant protein-1 (MCP-1) plays a crucial role in initiating coronary heart disease by recruiting monocytes/macrophages to the vessel wall. Transgenic mice with cardiac-specific expression of MCP-1 manifest cardiac inflammation and develop heart failure. The pathways mediating the detrimental effects of MCP-1 expression have not been defined. We postulate that the Fas ligand (FasL) derived from the infiltrating mononuclear cells causes death of cardiac cells resulting in the development of heart failure. Here, we tested this hypothesis by determining whether inhibition of FasL function through cardiac-specific expression of soluble Fas (sFas) would rescue the MCP-1 transgenic mice from developing heart failure. We generated mice with cardiac-specific expression of sFas and double homozygous transgenic mice that express both MCP-1 and sFas. Cardiac-specific expression of sFas in MCP mice, in fact, inhibited apoptosis of infiltrating mononuclear cells, normalized circulating C-reactive protein (CRP) levels, and prevented macrophage activation as well as production of proinflammatory cytokines, tumor necrosis factor (TNF)-alpha, interleukin (IL)-1beta, and IL-6 in the hearts. sFas expression resulted in restoration of cardiac structure, preservation of cardiac function, and a significant prolongation of survival of MCP mice. These results demonstrate that FasL released from infiltrating mononuclear cells plays a critical role in the detrimental effects of MCP-1 expression, and suggest that Fas/FasL signaling represents a novel therapeutic target for heart failure.
AuthorsJianli Niu, Asim Azfer, Michael F Deucher, Pascal J Goldschmidt-Clermont, Pappachan E Kolattukudy
JournalJournal of molecular and cellular cardiology (J Mol Cell Cardiol) Vol. 40 Issue 6 Pg. 810-20 (Jun 2006) ISSN: 0022-2828 [Print] England
PMID16678847 (Publication Type: Journal Article, Research Support, N.I.H., Extramural)
Chemical References
  • Chemokine CCL2
  • Cytokines
  • Fas Ligand Protein
  • Fasl protein, mouse
  • Membrane Glycoproteins
  • RNA, Messenger
  • Tumor Necrosis Factors
Topics
  • Animals
  • Apoptosis
  • Chemokine CCL2 (genetics, metabolism)
  • Cytokines (genetics)
  • Fas Ligand Protein
  • Gene Expression Regulation
  • Gene Targeting
  • Heart Failure (prevention & control)
  • Male
  • Membrane Glycoproteins (chemistry, genetics, metabolism)
  • Mice
  • Mice, Transgenic
  • Myocarditis (therapy)
  • Myocardium (cytology, metabolism, pathology)
  • Organ Specificity
  • RNA, Messenger (genetics, metabolism)
  • Solubility
  • Survival
  • Tumor Necrosis Factors (chemistry, genetics, metabolism)
  • Ventricular Function

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: